Oramed Pharmaceuticals (ORMP) Non Operating Investment Income (2011 - 2014)
Oramed Pharmaceuticals (ORMP) posted Non Operating Investment Income of $160000.0 for Q3 2014, up 544.44% on a QoQ basis from -$36000.0 in Q2 2014, and up 200.52% year-over-year from $53241.7 in Q3 2013.
Oramed Pharmaceuticals (ORMP) Non Operating Investment Income (2011 - 2014) Analysis & Trends
Oramed Pharmaceuticals' Non Operating Investment Income history runs 3 years deep, the most recent figure standing at $160000.0 for Q3 2014.
- Quarterly Non Operating Investment Income rose 200.52% year-over-year to $160000.0 in Q3 2014, while the trailing twelve-month figure through Aug 2014 was $168391.0 (up 287.1% YoY) and the FY2014 annual result came in at $80000.0, up 188.89% from the prior year.
- Non Operating Investment Income was $160000.0 for Q3 2014 at Oramed Pharmaceuticals, up from -$36000.0 in the prior quarter.
- Across five years, Non Operating Investment Income topped out at $1.0 million in Q2 2011 and bottomed at -$159178.0 in Q3 2013.
- A 3-year average of $138924.4 and a median of $22214.0 in 2013 frame the typical range for Non Operating Investment Income.
- Peak annual rise in Non Operating Investment Income reached 200.52% in 2014, while the deepest fall reached 294.69% in 2014.
- Oramed Pharmaceuticals' Non Operating Investment Income stood at $1.0 million in 2011, then tumbled by 98.21% to $18454.0 in 2013, then jumped by 767.02% to $160000.0 in 2014.
- Business Quant data shows ORMP's Non Operating Investment Income at $160000.0 in Q3 2014, -$36000.0 in Q2 2014, and $25937.0 in Q1 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,831.58 Bn | 66,831.30 Bn | - | - |
| 2 | Nanobiotix | 1,916.61 Bn | 1,916.55 Bn | - | - |
| 3 | Akari Therapeutics | 976.78 Bn | 976.78 Bn | - | - |
| 4 | BeOne Medicines | 471.48 Bn | 466.69 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.78 Bn | 114.53 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.87 Bn | 61.12 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 63.06 Bn | 63.06 Bn | - | - |
| 8 | Argenx Se | 55.78 Bn | 50.60 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.54 Bn | 34.53 Bn | 959.66 Mn | - |
| 10 | Oramed Pharmaceuticals | 169.37 Mn | 169.37 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Aug 31, 2014 | 160,000.00 |
| Aug 31, 2014 | 160,000.00 |
| May 31, 2014 | -36,000.00 |
| May 31, 2014 | -36,000.00 |
| Feb 28, 2014 | 25,937.00 |
| Feb 28, 2014 | 25,937.00 |
| Nov 30, 2013 | 18,454.00 |
| Nov 30, 2013 | 18,454.00 |
| Aug 31, 2013 | -159,178.00 |
| Aug 31, 2013 | -159,178.00 |
| May 31, 2013 | 18,491.00 |
| May 31, 2013 | 18,491.00 |
| Feb 28, 2013 | 50,687.00 |
| Feb 28, 2013 | 50,687.00 |
| May 31, 2011 | 1.03 Mn |
| May 31, 2011 | 1.03 Mn |